Evidence map›Paper›PMID 35781901›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2022

A Formylglycine-Peptide for the Site-Directed Identification of Phosphotyrosine-Mimetic Fragments.

Markus Tiemann, Eric Nawrotzky, Peter Schmieder, Leon Wehrhan, Silke Bergemann, Vera Martos, Wei Song, Christoph Arkona, Bettina G Keller, Jörg Rademann

Open access · hybridAbstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Fluorinated Protein-Ligand Complexes: A Computational Perspective.The journal of physical chemistry. B · 2024
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Markus TiemannDepartment of Biology, Chemistry, Pharmacy, Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Strasse 2+4, 14195, Berlin, Germany.
Eric NawrotzkyDepartment of Biology, Chemistry, Pharmacy, Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Strasse 2+4, 14195, Berlin, Germany.
Peter SchmiederLeibniz Institute of Molecular Pharmacology (FMP), Robert-Rössle-Strasse 10, 13125, Berlin, Germany.
Leon WehrhanDepartment of Biology, Chemistry, Pharmacy, Institute of Chemistry and Biochemistry, Freie Universität Berlin, Arnimallee 22, 14195, Berlin, Germany.
Silke BergemannDepartment of Biology, Chemistry, Pharmacy, Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Strasse 2+4, 14195, Berlin, Germany.
Vera MartosLeibniz Institute of Molecular Pharmacology (FMP), Robert-Rössle-Strasse 10, 13125, Berlin, Germany.
Wei SongDepartment of Biology, Chemistry, Pharmacy, Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Strasse 2+4, 14195, Berlin, Germany.
Christoph ArkonaDepartment of Biology, Chemistry, Pharmacy, Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Strasse 2+4, 14195, Berlin, Germany.
Bettina G KellerDepartment of Biology, Chemistry, Pharmacy, Institute of Chemistry and Biochemistry, Freie Universität Berlin, Arnimallee 22, 14195, Berlin, Germany.
Jörg RademannDepartment of Biology, Chemistry, Pharmacy, Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Strasse 2+4, 14195, Berlin, Germany.ORCID http://orcid.org/0000-0001-6678-3165
Freie Universität Berlin · DELeibniz Association · DE

Funding

Deutsche Forschungsgemeinschaft Project-ID 387284271 - SFB 1349
6 · The paper itself

Abstract

Discovery of protein-binding fragments for precisely defined binding sites is an unmet challenge to date. Herein, formylglycine is investigated as a molecular probe for the sensitive detection of fragments binding to a spatially defined protein site . Formylglycine peptide 3 was derived from a phosphotyrosine-containing peptide substrate of protein tyrosine phosphatase PTP1B by replacing the phosphorylated amino acid with the reactive electrophile. Fragment ligation with formylglycine occurred in situ in aqueous physiological buffer. Structures and kinetics were validated by NMR spectroscopy. Screening and hit validation revealed fluorinated and non-fluorinated hit fragments being able to replace the native phosphotyrosine residue. The formylglycine probe identified low-affinity fragments with high spatial resolution as substantiated by molecular modelling. The best fragment hit, 4-amino-phenyl-acetic acid, was converted into a cellularly active, nanomolar inhibitor of the protein tyrosine phosphatase SHP2.

Indexed as

Amino AcidsPeptidesAcetatesBinding SitesGlycineMolecular ProbesPhosphotyrosineAcetatesAmino AcidsGlycineMolecular ProbesN-formylglycinePeptidesPhosphotyrosineformylglycinefragment-based drug discoveryfragment ligationphosphatase inhibitorssite-directed screening

Identifiers

PMID35781901
PMCPMC9804470
OpenAlexW4283795596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.